With the support of


Bold thinking. Bolder actions. We are Medtronic.

We lead global healthcare technology and boldly attack the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. 

In everything we do, we are engineering the extraordinary.


Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and hospital outcomes. More information is available at


CERENOVUS, part of Johnson & Johnson Medical Devices Companies, is a global leader in neurovascular care. Our commitment to changing the trajectory of stroke is inspired by our long heritage and dedication to helping physicians protect people from a lifetime of hardship. CERENOVUS offers a broad portfolio of devices used in the endovascular treatment of hemorrhagic and ischemic stroke.


MicroVention is a rapidly growing company that has pioneered the development of minimally invasive neuroendovascular technologies that provide therapeutic advantages for neurovascular disorders.


Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet need. Penumbra supports healthcare providers, hospitals and clinics in more than 100 countries. For more information, visit and connect on Twitter and LinkedIn. 


In the simplest sense, we’re a company that creates solutions for unmet clinical needs. More specifically, we design access device technology for neurovascular interventions. Because in the precious seconds that surround a stroke emergency, clinicians need technology that delivers. That’s where we come in.


We focus on providing innovative solutions for physicians in the treatment of ischemic and hemorrhagic stroke to drive superior outcomes for impacted individuals. 

We design, manufacture and deliver world-leading neurovascular products of the highest quality and conduct ourselves compliantly throughout the world. Link to our website here.


Philips is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum - from healthy living and prevention to diagnosis, treatment and home care. During the SLICE, Philips will showcase the Neurosuite solution that supports high levels of procedural efficiency to help and redefine outcomes for your neuro patients.




Sensome is developing the Clotild® Smart Guidewire System integrating an AI-powered microsensor to analyze clot features in real time and support physicians during mechanical thrombectomy for AIS.


Since its founding in 2006, Acandis, based in Pforzheim, Germany, is a forerunner and pioneer of current and future innovations in the field of minimally invasive endovascular technologies and solutions for the treatment of neurovascular diseases based on miniaturised medical technology.


Balt has been collaborating with physicians for more than 45 years by providing them with differentiated and clinically relevant solution for the treatment of patients with neurovascular diseases.


RapidAI is the global leader in using AI to combat life-threatening vascular and neurovascular conditions. Leading the next evolution of clinical decision-making and patient workflow, RapidAI is empowering physicians to make faster decisions for better patient outcomes. Based on intelligence gained from nearly 10 million scans in more than 2,000 hospitals in over 100 countries, the Rapid® platform transforms care coordination, offering care teams a level of patient visibility never before possible. RapidAI – where AI meets patient care.


Want to become a partner ?

Join us and participate in the practical training of practitioners in neuroscience, neurology, neurosurgery and neuroradiology.